Clofazimine Encapsulation in Nanoporous Silica Particles for the Oral Treatment of antibiotic-resistant <i>Mycobacterium Tuberculosis</i> Infections

Abstract

Promising results toward refurbishment of an approved marketed drug for a different indication suitable for oral anti-TB formulation.